Celanese Corporation to Participate in Fireside Discussion at Deutsche Bank 16th Annual Global Industrials and Materials Conference
With updated webcast link
DALLAS, June 05, 2025--(BUSINESS WIRE)--Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, today announced that Scott Richardson, President and Chief Executive Officer, will participate in a fireside discussion at the Deutsche Bank Global Industrials and Materials Conference on Thursday, June 5, 2025, at 11:50 AM Eastern Time.
A live webcast of the discussion and a replay of the webcast will be available at Celanese - Investor Relations on the Events Calendar page. The replay is expected to be available until June 5, 2026.
About Celanese
Celanese Corporation is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer and societal demand. We strive to make a positive impact in our communities and to foster inclusivity across our teams. Celanese Corporation employs more than 11,000 employees worldwide with 2024 net sales of $10.3 billion.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250604632162/en/
Contacts
Investor Relations Bill CunninghamPhone: +1 302 772 5231william.cunningham@celanese.com
Media - U.S. Jamaison SchulerPhone: +1 972 443 4400media@celanese.com
Media – Europe Petra CzuglerPhone: +49 69 45009 1206petra.czugler@celanese.com
Erreur lors de la récupération des données
Connectez-vous pour accéder à votre portefeuille
Erreur lors de la récupération des données
Erreur lors de la récupération des données
Erreur lors de la récupération des données
Erreur lors de la récupération des données
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Thousands of Convergint Colleagues Revitalize Hundreds of Communities and Increase School Safety Globally for Annual Day of Service
Convergint's 24th Annual Convergint Social Responsibility Day and STEP Up for Schools Initiative Benefit Underserved Communities and Needs of People Around the World SCHAUMBURG, Ill., June 06, 2025--(BUSINESS WIRE)--Today, more than 174 community organizations and 35 schools across 37 countries globally are stronger as nearly 11,000 volunteers from Convergint, a global systems integrator with 220 locations worldwide, volunteered approximately 60,000 hours of their time for the company's 24th annual Convergint Social Responsibility Day. This year's efforts include support from over 30 partners across the industry who also volunteered their time and over $639,000 in donations of goods and services. The day also includes donations of security technology to over 20 schools as part of the organization's STEP Up for Schools initiative — a vital program to create safer learning environments for students and educators across the globe. "We are proud that today, and for nearly a quarter of a century, our colleagues and industry partners come together in just a 24-hour span as a greater force of good to give back to our communities," said Ann Fandozzi, CEO, Convergint. "Helping address unmet needs in the communities where Convergint colleagues and their families reside – including secure, safe educational environments to foster positive experiences for the next generation – is core to our values." In conjunction with Convergint Social Responsibility Day, the company continues its STEP (Secure, Train, Educate, Protect) Up for Schools Initiative to create safer learning environments for students and educators across the globe – a critical effort that supports underserved schools by donating critical security upgrades and hands-on assistance to help meet the unique safety needs of each campus. From installing new intrusion detection and video camera systems to helping with infrastructure improvements and other security and safety services, Convergint teams are working side by side with local partners and educators to build more secure, welcoming spaces where learning can thrive. To date, more than 100 STEP Up projects have been completed by Convergint and its partners, impacting communities globally. STEP Up projects underway around the world this year include: U.S. – Multiple projects across the country in Baltimore, MD; Knoxville, TN; Dallas, TX; Englewood, CO; Nashville, TN; San Diego, CA; and San Francisco, CA. For example, Colorado's Finest High School of Choice, serving over 300 students in Englewood, CO, is receiving 28 new cameras, 15 speakers, vape and aggression sensors, card reader and lockdown technologies. India – Captain Chandan Lal Special Middle School for the Blind in Gurugram is receiving an installation and donation of CCTV systems as well as painting and landscaping refurbishments. Thailand – Wat Sabok Khiao School in Nakhon Nayok will receive installation and donation of a solar pole, providing light source to illuminate the area as most students ride their bicycle to school, and food for 58 students and faculty. While Convergint Social Responsibility Day has an impact around the globe, in the US alone over 5,000 Convergint volunteers came together, spending over 43,000 hours of their time supporting over 90 community organizations. About Convergint Social Responsibility Day and STEP Up for Schools Since 2002, on the first Friday in June, for Convergint Social Responsibility Day (CSRD) the company closes for a full, paid workday so that colleagues can serve in their communities through various service projects. Convergint established its STEP Up for Schools Initiative as part of CSRD to help strengthen school security. Through the program, Convergint provides free safety and security installations, upgrades, and assessments to underserved schools across the globe. These initiatives are aimed at giving back and creating impactful change in communities around the world, and Convergint Social Responsibility Day strives to inspire all colleagues to surpass what they believe is possible. To learn more about Convergint's STEP Up for Schools program and apply, visit: About Convergint Convergint is a $2.6 billion global, industry-leading systems integrator that designs, installs, and services electronic security, cybersecurity, fire and life safety, building automation, and audio-visual systems. Listed as the #1 systems integrator in SDM Magazine's Top Systems Integrators Report for the past 6 years, Convergint leads with over 10,000 colleagues and more than 220 locations worldwide. To learn more about Convergint, visit View source version on Contacts Convergint PRConvergint@ Tommasina Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29 minutes ago
- Yahoo
WEIS MARKETS, INC. SHARE PURCHASE AGREEMENT
SUNBURY, Pa., June 6, 2025 /PRNewswire/ -- Weis Markets, Inc. (the "Company") announced effective June 6, 2025 that it has purchased in a private transaction 2,153,846 shares (the "Shares") of the Company's Common Stock, no par value ("Common Stock") for an aggregate purchase price of $140,000,000, or approximately $65.00 per share, pursuant to a Share Purchase Agreement (the "Purchase Agreement") among the trustees of The Patricia R. Weis Marital Trust and The Patricia G. Ross Weis Revocable Trust (collectively, the "Sellers") and the Company. The Sellers are affiliated with Jonathan H. Weis, the Chairman, President, and CEO of the Company, and other members of the Weis family (collectively, the "Weis Family"). The Sellers will use the proceeds from the sale principally to satisfy estate tax obligations of the estate of Patricia R. Weis. Following the sale, the Sellers continue to own 4,051,383 shares of Common Stock, and members of the Weis Family remain owners of approximately 61% of the outstanding Common Stock. The approximate $65.00 per share purchase price represents a 12.3% discount to the closing price of the Common Stock as of June 5, 2025, a 15.6% discount to the 30-day volume weighted average trading price of the Common Stock as of June 5, 2025, a 12.8% discount to the 180-day volume weighted average trading price of the Common Stock as of June 5, 2025, and a 8.4% discount to the 1-year volume weighted average trading price of the Common Stock as of June 5, 2025. The Company funded the purchase by a combination of cash on hand and cash from the sale of marketable securities. The Purchase Agreement contains customary representations, warranties, and covenants of the parties. The Purchase Agreement was approved by the Company's Board of Directors (other than Jonathan H. Weis who recused himself from voting), after having been negotiated and recommended by a special committee of the Company's Board of Directors (the "Special Committee"), consisting solely of disinterested, independent directors. Kroll, LLC (acting through its Duff & Phelps Opinion Practice) was independent financial advisor to the Special Committee and provided a customary fairness opinion. K&L Gates LLP acted as counsel to the Special Committee. Reed Smith LLP was counsel to the Company, and Paul, Weiss, Rifkind, Wharton & Garrison LLP represented the Sellers. About Weis Markets Founded in 1912, Weis Markets, Inc. (NYSE: WMK) is a Mid Atlantic food retailer operating 198 stores in Pennsylvania, Maryland, Delaware, New Jersey, New York, West Virginia and Virginia. For more information, please visit: or In addition to historical information, this news release may contain forward-looking statements, which are included pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. For example, risks and uncertainties can arise with changes in: general economic conditions, including their impact on capital expenditures; tariffs and trade policies; business conditions and trends in the retail industry; the regulatory environment; rapidly changing technology, including cybersecurity and data privacy risks, and competitive factors, including increased competition with regional and national retailers; and price pressures. Readers are cautioned not to place undue reliance on forward-looking statements, which reflect Management's analysis only as of the date hereof. The Company undertakes no obligation to publicly revise or update these forward-looking statements to reflect events or circumstances that arise after the date hereof. Readers should carefully review the risk factors described in other documents the Company files periodically with the Securities and Exchange Commission. View original content to download multimedia: SOURCE Weis Markets Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29 minutes ago
- Yahoo
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors
Pivotal Study Advances to Establish Histotripsy as a Non-Thermal, Surgery-Free Alternative to Destroy and Liquefy Kidney Tumors MINNEAPOLIS, June 06, 2025--(BUSINESS WIRE)--HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison System remains in investigational use for kidney applications and is not yet FDA-approved for this indication. Data from the #HOPE4KIDNEY trial is expected to support a future submission for regulatory clearance to expand the use of histotripsy to treat kidney tissue/tumors. The Edison System is the first and only platform to use histotripsy, a non-thermal, non-invasive focused ultrasound technology, to mechanically liquefy tumors without surgery, radiation, or systemic therapies. Unlike invasive surgical approaches, histotripsy does not require incisions and enables real-time imaging and treatment monitoring, allowing physicians to target and control tissue destruction while sparing surrounding structures. "Our vision is for the Edison System to become a foundational, non-invasive solution across a wide range of clinical applications," said Mike Blue, President and CEO, HistoSonics. "Completing enrollment in our pivotal kidney tumor trial represents a significant milestone toward that goal and reinforces our confidence in expanding histotripsy into additional tumor types and indications. This achievement reflects the dedication of our team and clinical partners and brings us closer to transforming the treatment of solid tumors without the need for surgery." Dr. William C. Huang, MD FACS, Professor and Vice Chair of Urology at the NYU Grossman School of Medicine serves as a principal investigator at the NYU Langone Medical Center, the top enrolling site in the trial. Dr. Huang commented, "Histotripsy offers a novel, completely non-invasive treatment paradigm for kidney tumors that precisely images and treats tumors while preserving surrounding critical structures thereby minimizing the morbidity associated with traditional surgical and thermal ablative techniques." Dr. Michael McDonald, Assistant Professor of Urology at the University of Central Florida College of Medicine and Urologic Surgeon at AdventHealth at Celebration Florida, serves as a principal investigator for one of the participating sites in the trial. Dr. McDonald commented, "HistoSonics represents a paradigm shift proving that the most profound treatments for both benign and malignant diseases need not be the most invasive. The ability to precisely target and destroy tumors without scalpel or scar is the next step in the evolution of non-surgical intervention." The Edison System has not been evaluated for the treatment of any specific disease, including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumour progression, 5-year survival or overall survival). United States Intended Use Statement: The Edison System is intended for the non-invasive mechanical destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors via histotripsy. The FDA has not evaluated the Edison System for the treatment of any disease including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumor progression, 5-year survival or overall survival). The System should only be used by physicians who have completed training performed by HistoSonics, and its use guided by the clinical judgment of an appropriately trained physician. Refer to the device Instructions for Use for a complete list of warnings, precautions, and a summary of clinical trial results, including reported adverse events. About HistoSonics HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors. The company is currently focused on commercializing their Edison System in the US and select global markets for liver treatment while expanding histotripsy applications into other organs like kidney, pancreas, prostate, and others. HistoSonics has offices in Ann Arbor, Michigan and Minneapolis, MN. For more information on the Edison Histotripsy System please visit: For patient-related information please visit: View source version on Contacts Media contacts:Josh KingVice President of 608.332.8124 Kimberly HaKKH Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
